These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19293668)

  • 21. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.
    Jensen LO; Kaltoft A; Thayssen P; Tilsted HH; Christiansen EH; Mikkelsen KV; Maeng M; Hansen KN; Villadsen AB; Madsen M; Lassen JF; Pedersen KE; Thuesen L
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):101-8. PubMed ID: 19670299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
    Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
    Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
    Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
    Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PCI is now a refined method for treatment of coronary stenoses].
    Tornvall P; Nilsson T; Jensen J
    Lakartidningen; 2005 Sep 5-11; 102(36):2478-81. PubMed ID: 16196433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention.
    Mangiacapra F; De Bruyne B; Muller O; Trana C; Ntalianis A; Bartunek J; Heyndrickx G; Di Sciascio G; Wijns W; Barbato E
    JACC Cardiovasc Interv; 2010 Jan; 3(1):35-40. PubMed ID: 20129566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease.
    McClure SJ; Gall S; Schechter CB; Kearney M; Zaman AG
    J Am Coll Cardiol; 2007 Jun; 49(25):2394-7. PubMed ID: 17599601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial progenitor cell mobilization after percutaneous coronary intervention.
    Banerjee S; Brilakis E; Zhang S; Roesle M; Lindsey J; Philips B; Blewett CG; Terada LS
    Atherosclerosis; 2006 Nov; 189(1):70-5. PubMed ID: 16806234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial.
    Bui AH; Bonaca MP; Sabatine MS; Ray KK; Rifai N; Cannon CP; Morrow DA
    J Thromb Thrombolysis; 2012 Aug; 34(2):222-8. PubMed ID: 22446996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention.
    Stabile E; Nammas W; Salemme L; Sorropago G; Cioppa A; Tesorio T; Ambrosini V; Campopiano E; Popusoi G; Biondi Zoccai G; Rubino P
    J Am Coll Cardiol; 2008 Oct; 52(16):1293-8. PubMed ID: 18929239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
    Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
    JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris.
    Grøgaard HK; Solheim S; Landsverk KS; Seljeflot I; Hoffmann P; Arnesen H; Ilebekk A
    Scand J Clin Lab Invest; 2011 Jul; 71(4):322-9. PubMed ID: 21463159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease.
    Senturk T; Aydinlar A; Yilmaz Y; Oral AY; Ozdabakoglu O; Ulukaya E
    Coron Artery Dis; 2009 Dec; 20(8):494-8. PubMed ID: 19770641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.
    Gibson CM; Kirtane AJ; Boundy K; Ly H; Karmpaliotis D; Murphy SA; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2005 Feb; 45(3):357-62. PubMed ID: 15680712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.
    Gibson CM; Buros J; Ciaglo LN; Southard MC; Takao S; Harrigan C; Filopei J; Lew M; Marble SJ; Murphy SA; Cohen MG;
    Am J Cardiol; 2007 Jul; 100(1):13-7. PubMed ID: 17599433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Wang Y; Johnsen HE; Mortensen S; Bindslev L; Ripa RS; Haack-Sørensen M; Jørgensen E; Fang W; Kastrup J
    Heart; 2006 Jun; 92(6):768-74. PubMed ID: 16251230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.